ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma

Shi, Linyong; Chen, Hanning; Chen, Kunxiang; Zhong, Chengzong; Song, Chong; Huang, Yifeng; Wang, Tong; Chen, Lei; Li, Chiyang; Huang, Annie; Qi, Songtao; Li, Hong*; Lu, Yuntao*南方医科大学
Clinical Cancer Research2023-8-15DOI: 10.1158/1078-0432.CCR-22-3971
2被引4阅读
引用收藏
分享

摘要

Purpose: Temozolomide resistance remains a major obstacle in the treatment of glioblastoma (GBM). The combination of temo-zolomide with another agent could offer an improved treatment option if it could overcome chemoresistance and prevent side effects. Here, we determined the critical drug that cause ferroptosis in GBM cells and elucidated the possible mechanism by which drug combination overcomes chemoresistance.Experimental Design: Haloperidol/temozolomide synergism was assessed in GBM cell lines with different dopamine D2 receptor (DRD2) expression in vitro and in vivo. Inhibitors of ferroptosis, autophagy, endoplasmic reticulum (ER) stress and cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) were used to validate the specific mechanisms by which haloperidol and temo-zolomide induce ferroptosis in GBM cells.Results: In the present work, we demonstrate that the DRD2 level is increased by temozolomide in a time-dependent manner and is inversely correlated with temozolomide sensitivity in GBM. The DRD2 antagonist haloperidol, a butylbenzene antipsychotic, markedly induces ferroptosis and effectively enhances temozolomide efficacy in vivo and in vitro. Mechanis-tically, haloperidol suppressed the effect of temozolomide on cAMP by antagonizing DRD2 receptor activity, and the increases in cAMP/PKA triggered ER stress, which led to autophagy and ferroptosis. Furthermore, elevated autophagy mediates downregulation of FTH1 expression at the posttrans-lational level in an autophagy-dependent manner and ultimately leads to ferroptosis.Conclusions: Our results provide experimental evidence for repurposing haloperidol as an effective adjunct therapy to inhibit adaptive temozolomide resistance to enhance the efficacy of che-moradiotherapy in GBM, a strategy that may have broad prospects for clinical application.

学科与关键词

关键词
CELL-DEATHER STRESSDEGRADATIONPATHWAYBIOLOGY
相关
加载中…
  • Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
    Qu, Shanqiang; Qi, Songtao; Zhang, Huayang; Li, Zhiyong; Wang, Kaicheng; Zhu, Taichen; Ye, Rongxu; Zhang, Wanghao; Huang, Guanglong*; Yi, Guo-zhong*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42(1): 285.被引 1
  • Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma
    Kiang, Karrie Mei-Yee; Tang, Wanjun; Song, Qingchun; Liu, Jiaxin; Li, Ning; Lam, Tsz-Lung; Shum, Ho Cheung; Zhu, Zhiyuan*; Leung, Gilberto Ka-Kit*British Journal of Cancer, 2023, 128(10): 1955-1963.被引 6
  • A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma
    Cai, Yonghua; Liang, Xianqiu; Zhan, Zhengming; Zeng, Yu; Lin, Jie; Xu, Anqi; Xue, Shuaishuai; Xu, Wei; Chai, Peng; Mao, Yangqi; Song, Zibin; Han, Lei; Xiao, Jianqi*; Song, Ye*; Zhang, Xian*Frontiers in Cell and Developmental Biology, 2022, 9: 812422.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Clinical Cancer Research
发表日期
2023-08-15
卷期
第 29 卷, 第 16 期
页码
3172-3188
DOI
10.1158/1078-0432.CCR-22-3971
语言
ENGLISH
成果收录
SCIE
资助标注
General Programs from the National Natural Science Foundation of China [81902544, 82073305, 81972355]; Natural Science Foundation of Guangdong Province [2020A1515010063, 2021A1515010711]; Outstanding Youth Development Scheme of Nanfang Hospital, Southern Medical University [2020J006]; Guangdong Basic and Applied Basic Research Foundation [2019B151502048]; National Key Clinical Specialty Project; Dalian Medical Science Research ProgramProject [2111001]; Dalian Key Medical Specialty Dengfeng Project [2022ZZ211]; Grant for Recruited Talents to Start Scientific Research from Nanfang Hospital

作者

  • S

    Shi, Linyong (第一作者)

    southern med univ

  • C

    Chen, Hanning

    southern med univ

查看全部 13 位作者收起作者
  • C

    Chen, Kunxiang

    southern med univ

  • Z

    Zhong, Chengzong

    southern med univ

  • S

    Song, Chong

    southern med univ · dalian univ technol

  • H

    Huang, Yifeng

    southern med univ

  • W

    Wang, Tong

    southern med univ

  • C

    Chen, Lei

    southern med univ

  • L

    Li, Chiyang

    southern med univ

  • H

    Huang, Annie

  • Q

    Qi, Songtao

    southern med univ

  • L

    Li, Hong (通讯)

    southern med univ

  • L

    Lu, Yuntao (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417